TrovaGene Inc (NASDAQ: TROV) is having a great start to the trading session this morning, trading up more than 18% after announcing positive preclinical data… Read More »TrovaGene (TROV) Stock: Making A Run On New Data
Biotech Stock News
Moleculin Biotech Inc (NASDAQ: MBRX) has been climbing in the market over the past couple of trading sessions, with gains of more than 30% today… Read More »Moleculin Biotech (MBRX) Stock: Why Now May Be The Time To Get Involved
Precipio Inc (NASDAQ: PRPO) is a company that I’ve been following closely as of late. For those of you that haven’t gotten familiar with the… Read More »Precipio (PRPO) Stock: This Update Could Change The Game!
Amyris Inc (NASDAQ: AMRS) is having an overwhelmingly rough day in the market today, trading down 21.07% at the time of writing this article. While… Read More »Amyris (AMRS) Stock: Buy The Dip, Thank Me Later!
Avinger Inc (NASDAQ: AVGR) is having a strong day in the market today, gaining more than 12% after announcing an FDA 510(k) clearance. With the… Read More »Avinger (AVGR) Stock: Recent News Makes This A Strong Buy!
Precipio Inc (NASDAQ: PRPO) has been a big topic of conversation as of late, and for good reason. After announcing positive news from on client… Read More »Precipio (PRPO) Stock: Why It’s Time To Jump In Head First!
Novavax, Inc. (NASDAQ: NVAX) has been an interesting stock to follow as of late. After trading in the low-to-mid $2 range early on in the… Read More »Novavax (NVAX) Stock: Is Now The Time To Jump In?
TrovaGene Inc (NASDAQ: TROV) has been a hot topic of discussion among the biotech investing community as of late. With consistent news releases coming out… Read More »TrovaGene (TROV) Stock: Is Now The Time To Dive In?
Seelos Therapeutics Inc (NASDAQ: SEEL) had a great day in the market on Thursday. By the closing bell, the stock was trading at $3.22 per… Read More »Seelos Therapeutics (SEEL) Stock: Something Big Is On The Horizons
AVEO Pharmaceuticals, Inc. (NASDAQ: AVEO) is having an impressive day in the market today, up 37.79% at the moment and climbing. Although, the company hasn’t… Read More »AVEO Pharmaceuticals (AVEO) Stock: Is An Acquisition On The Horizons?